Weiss Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Weiss Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-577,247	Closed	-$10.9M	–	445
2019 Q3	$10.9M	Buy	+577,247	New	+$6.6M	0.87%	32
2018 Q4	–	Sell	-10,882	Closed	-$181K	–	513
2018 Q3	$181K	Buy	+10,882	New	+$197K	0.01%	154

Weiss Asset Management's ALDR Position: Q4 2019 in Review

Weiss Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 577,247 shares — an estimated $10.9M sold.

Weiss Asset Management first reported a position in ALDR in Q3 2018 and held it in 2 quarters. The position peaked at $10.9M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Weiss Asset Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Weiss Asset Management sold 577,247 Alder Biopharmaceuticals shares in Q4 2019, an estimated $10.9M.
Weiss Asset Management first reported a position in Alder Biopharmaceuticals in Q3 2018 and held it in 2 quarters.
Weiss Asset Management's Alder Biopharmaceuticals position peaked at $10.9M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Weiss Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.